Innate Pharma reports today its consolidated financial results for the year ending December 31, 2009 and updates on its drug candidates
Innate Pharma reports operating revenue of 7.7 million euros for 2009
Number of shares and voting rights and cash situation of INNATE PHARMA as at December 31, 2009